このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

MedikitLtd マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Yoji Kageyama

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	3yrs
CEOの所有権	0.1%
経営陣の平均在職期間	3yrs
取締役会の平均在任期間	9yrs

経営陣の近況

Recent updates

Update: MedikitLtd (TYO:7749) Stock Gained 79% In The Last Five Years

Mar 12

Is MedikitLtd (TYO:7749) Likely To Turn Things Around?

Feb 22

Has Medikit Co.,Ltd. (TYO:7749) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Feb 02

CEO（最高経営責任者

Yoji Kageyama (64 yo)

3yrs

在職期間

Mr. Yoji Kageyama is President & Representative Director of Medikit Co.,Ltd. from June 2021. He joined the Medikit Co.,Ltd.in May 1986. He was MD of Sales Department, East Japan Overseas Business Division...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Hiroaki Nakajima	Founder	no data	JP¥131.10m	0% ¥ 0
Yoji Kageyama	President & Representative Director	3yrs	データなし	0.12% ¥ 54.3m
Hiroshi Horinouchi	Sales Administration Department & Director	9.8yrs	データなし	0.060% ¥ 26.2m
Takashi Nakajima	Executive VP & Director	3yrs	データなし	5.71% ¥ 2.5b

3.0yrs

平均在職期間

64yo

平均年齢

経験豊富な経営陣: 7749の経営陣は経験豊富であると考えられます ( 3年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Yoji Kageyama	President & Representative Director	15yrs	データなし	0.12% ¥ 54.3m
Hiroshi Horinouchi	Sales Administration Department & Director	9yrs	データなし	0.060% ¥ 26.2m
Takashi Nakajima	Executive VP & Director	14yrs	データなし	5.71% ¥ 2.5b
Yasuyuki Yoshida	Independent External Director	9yrs	データなし	0.0027% ¥ 1.2m
Shuji Oshima	External Auditor	10yrs	データなし	データなし
Fumihiro Nakajima	Director	5yrs	データなし	0.012% ¥ 5.3m
Atsuko Otaki	Independent Outside Director	3yrs	データなし	データなし
Fukuichi Yoshida	Outside Corporate Auditor	3yrs	データなし	データなし
Naomichi Kaneko	Full Time Auditor	7yrs	データなし	0.054% ¥ 23.6m

9.0yrs

平均在職期間

64yo

平均年齢

経験豊富なボード: 7749の取締役会は経験豊富であると考えられます ( 9年の平均在任期間)。

MedikitLtd マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Medikit Co.,Ltd., Annual General Meeting, Jun 26, 2024

Medikit Co.,Ltd., Annual General Meeting, Jun 28, 2023

Less than half of directors are independent

Medikit Co.,Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Recent updates

Medikit Co.,Ltd. to Report Q1, 2025 Results on Aug 09, 2024

Full year 2024 earnings released: EPS: JP¥188 (vs JP¥171 in FY 2023)

Medikit Co.,Ltd., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥35.00 per share

Medikit Co.,Ltd. to Report Fiscal Year 2024 Results on May 15, 2024

Third quarter 2024 earnings released: EPS: JP¥48.29 (vs JP¥55.53 in 3Q 2023)

Medikit Co.,Ltd. (TSE:7749) announces an Equity Buyback for 2,200,100 shares, representing 13.1% for ¥5,253.84 million.

Medikit Co.,Ltd. to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥45.01 (vs JP¥39.26 in 2Q 2023)

Upcoming dividend of JP¥35.00 per share at 2.6% yield

Medikit Co.,Ltd. to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings released: EPS: JP¥33.60 (vs JP¥32.01 in 1Q 2023)

Medikit Co.,Ltd. to Report Q1, 2024 Results on Aug 10, 2023

Medikit Co.,Ltd., Annual General Meeting, Jun 28, 2023

Full year 2023 earnings released: EPS: JP¥171 (vs JP¥178 in FY 2022)

Upcoming dividend of JP¥30.00 per share at 2.5% yield

Third quarter 2023 earnings released: EPS: JP¥55.52 (vs JP¥45.28 in 3Q 2022)

Medikit Co.,Ltd. to Report Q3, 2023 Results on Feb 10, 2023

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥39.26 (vs JP¥43.14 in 2Q 2022)

Medikit Co.,Ltd. to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: EPS: JP¥32.01 (vs JP¥40.17 in 1Q 2022)

Medikit Co.,Ltd. to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: EPS: JP¥178 (vs JP¥157 in FY 2021)

Medikit Co.,Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Medikit Co.,Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥50.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Medikit Co.,Ltd. (JASDAQ:7749) announces an Equity Buyback for 144,000 shares, representing 0.86% for ¥400 million.

Second quarter 2022 earnings released: EPS JP¥43.14 (vs JP¥34.21 in 2Q 2021)

Full year 2021 earnings released: EPS JP¥157 (vs JP¥170 in FY 2020)

Upcoming dividend of JP¥50.00 per share

Update: MedikitLtd (TYO:7749) Stock Gained 79% In The Last Five Years

Medikit Co.,Ltd. to Report Fiscal Year 2021 Results on May 14, 2021

Is MedikitLtd (TYO:7749) Likely To Turn Things Around?

Third quarter 2021 earnings released: EPS JP¥46.43 (vs JP¥48.84 in 3Q 2020)

Has Medikit Co.,Ltd. (TYO:7749) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Is Medikit Co.,Ltd. (TYO:7749) A Smart Choice For Dividend Investors?

Is Medikit Co.,Ltd.'s (TYO:7749) Shareholder Ownership Skewed Towards Insiders?

Investors Who Bought MedikitLtd (TYO:7749) Shares Five Years Ago Are Now Up 80%

Medikit Co.,Ltd. to Report Q3, 2021 Results on Feb 10, 2021

New 90-day low: JP¥2,950

Second quarter 2021 earnings released: EPS JP¥34.21

New 90-day low: JP¥3,015

New 90-day low: JP¥3,085

Medikit Co.,Ltd. to Report Q2, 2021 Results on Nov 12, 2020

New 90-day low - JP¥3,330

Earnings released

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24